 |
市場調查報告書
商品編碼
1768027
羥氯喹市場（按適應症、通路和地區分類）Hydroxychloroquine Market, By Disease Indication, By Distribution Channel, By Region |
||||||
價格
簡介目錄
羥氯喹市場規模預計在 2025 年為 6.703 億美元，預計到 2032 年將達到 9.881 億美元，2025 年至 2032 年的年複合成長率（CAGR）為 5.7%。
| 報告範圍 | 報告詳細資訊 | ||
|---|---|---|---|
| 基準年 | 2024 | 2025年的市場規模 | 6.703億美元 |
| 效能數據 | 2020-2024 | 預測期 | 2025-2032 |
| 預測期：2025-2032年 | 5.70% | 2032年價值預測 | 9.881億美元 |
羥氯奎在體外對流感、瘧疾、冠狀病毒和許多其他感染疾病等病毒表現出潛在活性。目前正在研究它作為 COVID-19 治療的有效性。武漢進行的一項研究表明，使用羥氯喹和Chloroquine治療後，冠狀病毒患者的體溫恢復時間和咳嗽緩解時間顯著縮短。儘管缺乏有力證據，但由於冠狀病毒（COVID-10）流行，對羥氯喹的需求激增。但是，必須監測劑量，因為過量服用羥氯喹會引起危險的副作用，例如嗜睡、視力心室心搏過速、心血管衰竭、抽搐、低血鉀、心律不整、心室心搏過速和心室顫動。這會導致呼吸驟停和心臟麻痹，從而危及生命。
市場動態
預計在預測期內，主要企業擴大採用非直接成長策略，例如建立合作夥伴關係和協作，以評估羥氯喹錠劑治療冠狀病毒病 (COVID-19) 患者的療效，將推動市場成長。例如，2020 年 3 月 27 日，製藥公司 Rising Pharma Holdings Inc. 與明尼蘇達大學感染疾病學院傳染病與全球健康系簽署了合作協定，探索羥氯喹作為冠狀病毒感染疾病(COVID-19) 預防性治療的可行性。
本研究的主要特點
- 本報告對全球羥氯喹市場進行了詳細分析，並提供了預測期 2025-2032 的市場規模和年複合成長率(CAGR)，假設 2024 年為基準年。
- 它還揭示了各個領域的潛在商機，並說明了該市場的有吸引力的投資提案矩陣。
- 它還提供了有關市場促進因素、限制因素、機會、新藥發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。
- 它根據公司概況、業績、產品系列、市場佔有率、分銷策略、關鍵發展、策略和未來計劃等參數，介紹了全球羥氯喹市場的主要企業概況。
- 本報告的見解將使負責人和公司經營團隊能夠就未來的藥品發布、疾病適應症升級、市場擴張和行銷策略做出明智的決策。
- 全球羥氯喹市場報告迎合了該行業的各個相關人員，例如投資者、供應商、製藥商、經銷商、新進入者和金融分析師。
- 相關人員將透過全球羥氯喹市場分析中使用的各種策略矩陣更輕鬆地做出決策。
目錄
第1章 調查目的與前提條件
- 研究目標
- 先決條件
- 簡稱
第2章 市場展望
- 報告描述
- 市場定義和範圍
- 執行摘要
第3章市場動態、法規與趨勢分析
- 市場動態
- 驅動程式
- 限制因素
- 市場機會
- 監管情景
- 產業趨勢
- 新疾病適應症的核准與上市
- 推廣及行銷活動
- 影響分析
- 最新產品發布
- 流行病學
- 合併、收購與合作
- 監管情景
- PEST分析
4. 全球羥氯喹市場-COVID-19影響分析
- 經濟影響
- COVID-19流行病學
- 對需求和供給的影響
5. 2020 年至 2032 年全球羥氯喹市場（依適應症分類）
- 介紹
- 瘧疾
- 冠狀病毒病
- 紅斑狼瘡
- 類風濕性關節炎
6. 2020-2032 年全球羥氯喹市場（依通路）
- 介紹
- 醫院藥房
- 零售藥局
- 網路藥局
7. 2020-2032 年全球羥氯喹市場（按地區）
- 介紹
- 北美洲
- 美國
- 加拿大
- 拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲
- 歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
- 亞太地區
- 中國
- 印度
- 日本
- 東南亞國協
- 澳洲
- 韓國
- 其他亞太地區
- 中東
- 海灣合作理事會國家
- 以色列
- 其他中東地區
- 非洲
- 北非
- 中部非洲
- 南非
第8章 競爭態勢
- Sanofi
- Amneal Pharmaceuticals, LLC
- Laurus Labs
- Zydus Group
- Prasco, LLC
- Reddy's Laboratories, Ltd
- Cadila Pharmaceuticals
- Novartis AG
- Concordia Pharmaceuticals Inc.（隸屬於 Advanz Pharma）
- Covis Pharma GmbH
- Cardinal Health
- Aphena Pharma Solutions
- Mylan NV（Viatris 的子公司）
- McKesson Corporation
- Teva Pharmaceutical Industries Ltd
- Lupin
- Sun Pharmaceutial Industries Ltd
第9章 章節
- 調查方法
- 關於出版商
簡介目錄
Product Code: CMI3727
Hydroxychloroquine Market is estimated to be valued at USD 670.3 Mn in 2025 and is expected to reach USD 988.1 Mn by 2032, growing at a compound annual growth rate (CAGR) of 5.7% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 670.3 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 5.70% | 2032 Value Projection: | USD 988.1 Mn |
Hydroxychlorquine exhibits the potential invitro activity against viruses including influenza, malaria, coronavirus, and many other diseases. The drug is under investigation to determine its efficacy for the treatment of novel coronavirus disease (COVID 19). According to the studies conducted in Wuhan, the body temperature recovery time and the cough remission time of coronavirus patients were significantly reduced with hydroxycloroquine and chloroquine treatment.Despite the absence of strong evidence, the demand for hydroxychloroquine has spiked due to the coronavirus (COVID 19) outbreak. However, the doses of hydroxychloroquine need to be monitored, as its overdose can have dangerous side effects such as drowsiness, visual disturbances, cardiovascular collapse, convulsions, hypokalemia, rhythm, ventricular tachycardia, and ventricular fibrillation. This may lead to sudden respiratory and cardiac arrest, which can be fatal.
Market Dynamics
The increasing adoption of inorganic growth strategies such as partnerships and collaborations by key players to evaluate the efficacy of hydroxchloroquine tablets for the treatment of patients with coronavirus disease (COVID 19) are expected to propel the market growth over the forecast period. For instance, on March 27, 2020, Rising Pharma Holdings Inc., a pharmaceutical company, entered into a collaborative agreement with the Division of Infectious Disease and International Medicine at the University of Minnesota, Department of Infectious Disease, to explore hydroxchloroquine as preventive treatment for coronavirus disease (COVID 19).
Key features of the study:
- This report provides in-depth analysis of the global hydroxchloroquine market, and provides market size (US$ Mn) and compound annual growth rate (CAGR) for the forecast period 2025-2032, considering 2024 as the base year.
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global hydroxchloroquine market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans.
- Key companies covered as a part of this study include Sanofi, Amneal Pharmaceuticals, LLC, Laurus Labs, Zydus Group, Prasco, LLC, Dr. Reddy's Laboratories, Ltd, Cadila Pharmaceuticals, Novartis AG, Concordia Pharmaceuticals Inc. (A subsidiary of Advanz Pharma), Covis Pharma GmbH, Cardinal Health, Aphena Pharma Solutions, Mylan N.V (A subsidiary of Vitris), McKesson Corporation, Teva Pharmaceutical Industries Ltd, Lupin, Sun Pharmaceutical Industries Ltd.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future drug launches, disease indication up-gradation, market expansion, and marketing tactics.
- The global hydroxchloroquine market report caters to various stakeholders in this industry including investors, suppliers, drug manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global hydroxchloroquine market.
Detailed Segmentation:
- Global Hydroxychloroquine Market, By Disease Indication:
- Malaria
- Coronavirus
- Lupus Erythematosus
- Rhematoid Arthritis
- Global Hydroxychloroquine Market, Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Global Hydroxychloroquine Market, By Region:
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
- Company Profiles
- Sanofi
- Amneal Pharmaceuticals, LLC,
- Laurus Labs,
- Zydus Group
- Prasco, LLC
- Reddy's Laboratories, Ltd
- Cadila Pharmaceuticals
- Novartis AG,
- Concordia Pharmaceuticals Inc. (A subsidiary of Advanz Pharma)
- Covis Pharma GmbH
- Cardinal Health
- Aphena Pharma Solutions,
- Mylan N.V (A susidary of Vitris)
- McKesson Corporation
- Teva Pharmaceutical Industries Ltd
- Lupin, Sun Pharmaceutical Industries Ltd
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Disease Indication
- Market Snippet, By Distribution Channel
- Market Snippet, By Country
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Regulatory Scenario
- Industry Trends
- New Disease Indication Approval/Launches
- Promotion And Marketing Initiatives
- Impact Analysis
- Recent Product Launches
- Epidemiology
- Merger, Acquisition, and Collaborations
- Regulatory Scenario
- Key Developments
- PEST Analysis
4. Global Hydroxychloroquine Market- COVID-19 Impact Analysis
- Economic Impact
- COVID-19 Epidemiology
- Impact on Supply and Demand
5. Global Hydroxychloroquine Market, By Disease Indication, 2020-2032, (US$ Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
- Malaria
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
- Coronavirus Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
- Lupus Erythematosus
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
- Rheumatid Arthritis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
6. Global Hydroxychloroquine Market, By Distribution Channel, 2020-2032, (US$ Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
7. Global Hydroxychloroquine Market, By Region, 2020-2032, (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Regions, 2021-2032
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel 2020 - 2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, Distribution Channel, 2020 - 2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, Distribution Channel, 2020 - 2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (US$ Mn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, Distribution Channel, 2020 - 2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (US$ Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, Distribution Channel, 2020 - 2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, Distribution Channel, 2020 - 2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (US$ Mn)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Sanofi
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Amneal Pharmaceuticals, LLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Laurus Labs
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Zydus Group
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Prasco, LLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Reddy's Laboratories, Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Cadila Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Novartis AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Concordia Pharmaceuticals Inc. (A subsidiary of Advanz Pharma)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Covis Pharma GmbH
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Cardinal Health
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Aphena Pharma Solutions
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Mylan N.V (A subsidiary of Viatris)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- McKesson Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Teva Pharmaceutical Industries Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Lupin
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Sun Pharmaceutial Industries Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
9. Section
- Research Methodology
- About Us
02-2729-4219
+886-2-2729-4219
羥氯喹和Chloroquine市場：類型、應用、區域範圍和預測
羥氯喹市場規模、佔有率和成長分析（按應用、最終用戶和地區）- 2025-2032 年產業預測全球羥氯喹藥物市場預測（2025-2030）